Intellia Therapeutics Financial Overview
Intellia Therapeutics's market cap is currently $1.07B. The company's EPS TTM is $-0.92; its P/E ratio is -2.16; Intellia Therapeutics is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $-0.96. See an overview of income statement, balance sheet, and cash flow financials.
